Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
If we are undervalued I presume our key shareholders will be keen to buy us cheaply & in the event of that occurring it would be unlikely to be at a higher level than the last raise - unless it happens 2 years from now , by when we may be cash flow positive.Similarly-if Greg & Santosh think we are ridiculously undervalued, they would both be buying large numbers of our shares.
Underdelivered ? They are achieving 20% quarterly growth rate
Unfortunately a lack of trust based on history, over promising, under delivery and now perceived lack of control. Also concerns about potential covenant breaks, if they don’t hit targets, Hopefully this is a big kick up the proverbial snd they focus on delivery.
If so, I agree, undervalued.
They pushed out cash break-even by at least 6 months, and given current cash balance, the market knows they will need to raise again. Place your bets on what price that raise will be at.
Underlying fundamentals are great, but communications and management have been awful
I wish I had your confidence in that
Very well and clear presentation showing that the company is progressing very well. The issue here is that they should talk from the very beginning about revenuers and not about prescriptions. They have done exactly what they said and achieved approximately three times more revenues compared to last year. It is very strange to see a company increasing its revenues almost 3 times more and having a share drop of more than 50%. The market took it very wrong thus the fall of the sp. It will certainly bounce back and reaching its target price n the future.
Consensus EPS estimates fall by 13%, revenue upgraded
The consensus outlook for fiscal year 2023 has been updated.
2023 revenue forecast increased from US$14.8m to US$15.3m.
Forecast EPS reduced from -US$0.033 to -US$0.037 per share.
Pharmaceuticals industry in the United Kingdom expected to see average net income growth of 29% next year.
Consensus price target of UK£0.15 unchanged from last update.
Share price fell 52% to UK£0.028 over the past week.
They seek forgiveness for their lies, after the leaked fund raise. Classic aim company
Many thanks
Here you go :
https://www.youtube.com/watch?v=ZPjiX-VY3Cg
Anyone got a link for the presentation
I think it’s a better more open presentation than the last one in all fairness…
No mention of headway in the colonies
However they may just pull the rabbit out of the hat!!
I bet the Chairman is delighted with his purchase how to make 122k in to 61k. give it to Greg to manage.
Technically yes but execution has to be spot on from here to make that happen.
What is the likelihood of that?
I thought that.... Says they have had the scissors out to cut costs..
Did he just say in a long-winded way say they have sufficient cash to get them to positive operating cash flow in 2025? nb. as a result of some fundamental changes to wc mgmt, etc. Surely this is basic stuff so why wasn't it done before?
Almost definitely won't, or a nonsense response, shambles management
Can sell all 500,000 but not get any to buy
It looks like you just took the last lot of shares available at 3p. Nothing left now at 3p on HL & IG platforms
@ 3p this is way undervalued and i am confident the market will wake up to this soon.
I am sure Greg will be as enthusiastic as ever despite the decimation of our SP on his watch.
Interesting to see if he responds to questions regarding progress in S Korea,Canada & China- or any other incisive questions
CEO, Greg Madison, and CFO, Santosh Shanbhag, will be hosting a live online presentation relating to the trading update via the Investor Meet Company platform at 14:00 (GMT) on Thursday 22 February 2024.....should be an interesting meeting
What a bounce back 4.5% woohoo! I'm not buying another share on the wild west of AIM again, over to the US market for me where there's some serious liquidity...